...
首页> 外文期刊>Diabetes care >Statin Use Is Prospectively Associated With New-Onset Diabetes After Transplantation in Renal Transplant Recipients
【24h】

Statin Use Is Prospectively Associated With New-Onset Diabetes After Transplantation in Renal Transplant Recipients

机译:在肾移植受者移植后,他汀类药物的使用是与新出售糖尿病相关联的

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE New-onset diabetes after transplantation (NODAT) is frequent and worsens graft and patient outcomes in renal transplant recipients (RTRs). In the general population, statins are diabetogenic. This study investigated whether statins also increase NODAT risk in RTRs. RESEARCH DESIGN AND METHODS From a prospective longitudinal study of 606 RTRs (functioning allograft >1 year, single academic center, follow-up: median 9.6 [range, 6.6-10.2] years), 95 patients using statins were age- and sex-matched to RTRs not on statins (all diabetes-free at inclusion). RESULTS NODAT incidence was 7.2% (73.3% of these on statins). In Kaplan-Meier (log-rank test,P= 0.017) and Cox regression analyses (HR 3.86 [95% CI 1.21-12.27];P= 0.022), statins were prospectively associated with incident NODAT, even independent of several relevant confounders including immunosuppressive medication and biomarkers of glucose homeostasis. CONCLUSIONS This study demonstrates that statin use is prospectively associated with the development of NODAT in RTRs independent of other recognized risk factors.
机译:移植后的目标新出售糖尿病(NODAT)频繁,肾移植受者(RTR)中的移植物和患者结果恶化。在一般人群中,他汀类药物是糖糖生成的。本研究调查了他汀类药物是否还增加了RTR的危险。来自606 rtrs的前瞻性纵向研究的研究和方法(运作同种异体移植物> 1年,单学术中心,随访:中位数9.6 [范围,6.6-10.2]岁),95名使用他汀类药物的患者是年龄和性别匹配的对他汀类药物(所有糖尿病在夹杂物上无)。结果结节发病率为7.2%(其他汀类药物中的73.3%)。在Kaplan-Meier(Log-Rank测试,P = 0.017)和Cox回归分析(HR 3.86 [95%CI 1.21-12.27]; P = 0.022),他汀类药物均与事件结婚,甚至独立于包括若干相关混淆葡萄糖稳态的免疫抑制药物和生物标志物。结论本研究表明,他汀类药物使用是与独立于其他公认的风险因素的RTR中的NODAT的发展相关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号